sacituzumab govitecan
gilead sciences
['tropics-02']
tropics-02 story from now updated with pfs curves --&gt; #asco22
Journalist at Evaluate Vantage. Proudly blocked by @JohnCendpts. Interested in: oncology, immunology. Not interested in: what stock you bought today.